CTOs on the Move

EngageMED

www.engagemed.com

 
Our mission at EngageMED is to provide innovative, value-based practice management and revenue cycle services to providers we engage throughout the state of Arkansas.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.engagemed.com
  • 5125 Northshore Drive
    North Little Rock, AR USA 72118
  • Phone: 501.224.1690

Executives

Name Title Contact Details

Similar Companies

Mosaic Dental Collective

We Put Our Patients First We’re a dental collective that’s lead by doctors and on a mission to put people at the center of dentistry. Get in Touch Partnerships Get the Support You Deserve Join a collective of dentists who work together to create a dent...

National Rural Health Association

National Rural Health Association is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthLynked

HealthLynked (OTCQB: HLYK) provides a solution for both patient members and providers to improve healthcare by efficiently exchanging medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take control of their medical data. Members can enter their medications, allergies, past surgeries, and personal health records into one convenient online and secure location. Participating healthcare providers can connect with their current and future patients through the HealthLynked Network. Providers also get the benefit of using HealthLynked marketing tools to communicate with their active and inactive patients to improve patient retention, access accurate patient information, and provide efficient online scheduling.

Cellenkos Incorporated

Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.